Human Pathology
Volume 36, Issue 5 , Pages 512-521 , May 2005

Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: An immunohistochemical study for OCT3/4 and TSPY

  • Anne-Marie F. Kersemaekers, PhD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • Both authors contributed equally to the work.
    • ,
  • Friedemann Honecker, MD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • Department of Hematology/Oncology, University of Tübingen, 72076 Tübingen, Germany
    • Both authors contributed equally to the work.
    • Current address: Department of Oncology and Hematology, University Hospital Hamburg Eppendorf, Martinstr. 52, 20246 Hamburg, Germany.
    • ,
  • Hans Stoop, BSc

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • ,
  • Martine Cools, MD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • ,
  • Michel Molier, BSc

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • Current address: Department of Oncology and Hematology, University Hospital Hamburg Eppendorf, Martinstr. 52, 20246 Hamburg, Germany.
    • ,
  • Katja Wolffenbuttel, MD

      Affiliations

    • Department of Pediatric Urology, Sophia Children's Hospital, Erasmus MC-University Medical Center Rotterdam, 3015 GJ Rotterdam, The Netherlands
    • ,
  • Carsten Bokemeyer, MD

      Affiliations

    • Department of Hematology/Oncology, University of Tübingen, 72076 Tübingen, Germany
    • ,
  • Yunmin Li, PhD

      Affiliations

    • Division of Cell and Developmental Genetics, Department of Medicine, VA Medical Center, University of California, San Francisco, CA 94121, USA
    • ,
  • Yun-Fai Chris Lau, PhD

      Affiliations

    • Division of Cell and Developmental Genetics, Department of Medicine, VA Medical Center, University of California, San Francisco, CA 94121, USA
    • ,
  • J. Wolter Oosterhuis, MD, PhD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • ,
  • Leendert H.J. Looijenga, PhD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author.

Received 1 February 2005 ,Accepted 15 February 2005.

References 

  1. Oosterhuis JW, Looijenga LHJ, Van Echten-Arends J, De Jong B. Chromosomal constitution and developmental potential of human germ cell tumors and teratomas. Cancer Genet Cytogenet. 1997;95:96–102
  2. Looijenga LHJ, Oosterhuis JW. Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol. 2002;24:263–279
  3. Woodward PJ, Heidenreich A, Looijenga LHJ, et al. World Health Organization classification of tumours. In:  Eble JN,  Sauter G,  Epstein JI,  Sesterhenn IA editor. Pathology and genetics of the urinary system and male genital organs. Lyon: IARC Press; 2004;p. 217–278[chapter 4]
  4. Scully RE. Gonadoblastoma/a review of 74 cases. Cancer. 1970;25:1340–1356
  5. Skakkebæk NE. Testicular dysgenesis syndrome. Horm Res. 2003;60(Suppl 3):49
  6. Skakkebæk NE, Holm M, Hoei-Hansen C, Jørgensen N, Rajpert-De Meyts E. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS. 2003;111:1–9
  7. Skakkebæk NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987;10:19–28
  8. Kildal W, Kraggerud SM, Abeler VM, Heim S, Trope CG, Kristensen GB, et al. Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female. Hum Pathol. 2003;34:946–949
  9. Hustin J, Gillerot Y, Collette J, Franchimont P. Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours. Virchows Arch. 1990;417:67–72
  10. Jørgensen N, Muller J, Jaubert F, Clausen OP, Skakkebæk NE. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology. 1997;30:177–186
  11. Slowikowska-Hilczer J, Walczak-Jedrzejowska R, Kula K. Immunohistochemical diagnosis of preinvasive germ cell cancer of the testis. Folia Histochem Cytobiol. 2001;39:67–72
  12. Hildenbrand R, Schroder W, Brude E, Schepler A, Konig R, Stutte HJ, et al. Detection of TSPY protein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. J Pathol. 1999;189:623–626
  13. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet. 2000;91:160–164
  14. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development. 1987;101:151–155
  15. Rutgers JL. Advances in the pathology of intersex conditions. Hum Pathol. 1991;22:884–891
  16. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, de la Chapelle A. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer. 1995;14:210–214
  17. Looijenga LHJ, Stoop H, De Leeuw PJC, De Gouveia Brazao CA, Gillis AJM, Van Roozendaal KEP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244–2250
  18. Honecker F, Stoop H, de Krijger R, Lau C, Bokemeyer C, Looijenga LHJ. Testicular carcinoma in situ markers in foetal germ cells: pathobiological implications. J Pathol. 2004;203:849–857
  19. Stoop H, Honecker F, Cools M, De krijger R, Bokemeyer C, Looijenga LHJ. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Hum Reprod. 2005;March 10 (online ahead)
  20. Rajpert-De Meyts E, Hanstein R, Jørgensen N, Græm N, Vogt PH, Skakkebæk NE. Developmental expression of POU5F1 (OCT3/4) in normal and dysgenetic human gonads. Hum Reprod. 2004;19(6):1338–1344
  21. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4:361–370
  22. Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol. 2004;28:1341–1346
  23. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer. 2004;101:2006–2010
  24. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol. 2004;28:935–940
  25. Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res. 2004;10:8544–8547
  26. Stoop H, Van Gurp RHJ, De Krijger R, Geurts van Kessel A, Koberle B, Oosterhuis JW, et al. Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest. 2001;81:919–928
  27. Kersemaekers AMF, Mayer F, Molier M, Van Weeren PC, Oosterhuis JW, Bokemeyer C, et al. Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol. 2002;20:1551–1561
  28. Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, Bartek J, et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS. 2003;111:267–278
  29. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet. 1996;5:1801–1807
  30. Looijenga LHJ, Rosenberg C, Van Gurp RJHLM, Geelen E, Van Echten-Arends J, De Jong B, et al. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and nonseminoma. J Pathol. 2000;19:187–192
  31. Rosenberg C, Van Gurp RJHLM, Geelen E, Oosterhuis JW, Looijenga LHJ. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene. 2000;19:5858–5862
  32. Datta MW, Renshaw AA, Dutta A, Hoffman MA, Loughlin KR. Evaluation of cyclin expression in testicular germ cell tumors: cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis. Mod Pathol. 2000;13:667–672
  33. Honecker F, Kersemaekers AMF, Molier M, Van Weeren PC, Stoop H, De Krijger RR, et al. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male foetal germ cell development. J Pathol. 2004;204:167–174

☆ This study was financially supported by the Dutch Cancer Society, grant number 2002 2682 (AMK, HS, JWO, LHJL), and the Deutsche Krebshilfe, Dr Mildred Scheel Stiftung (F.H.), and the European Society for Pediatric Endocrinology, ESPE sponsored by Novo Nordisk A/S (MC).

PII: S0046-8177(05)00085-7

doi: 10.1016/j.humpath.2005.02.016

Human Pathology
Volume 36, Issue 5 , Pages 512-521 , May 2005

Article Tools

* Image Usage & Resolution